Enlivex Ltd. (ENLV) stock
ENLVNasdaqFinance ServicesFiscal year ends December 31
$1.15+0.03 (+2.68%)
Close on Nov 17, 2026Market cap $19.36MP/E 0.0Yield –
Enlivex EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Enlivex's EPS for the twelve months ending Dec 31, 2016 was -$40.13. For fiscal 2025 it was $382.20. The highest annual figure on record is $382.20 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $382.20 | – |
| FY2024 | Dec 31, 2024 | -$10.95 | – |
| FY2023 | Dec 31, 2023 | -$23.40 | – |
| FY2022 | Dec 31, 2022 | -$25.35 | – |
| FY2021 | Dec 31, 2021 | -$12.15 | – |
| FY2020 | Dec 31, 2020 | -$13.50 | – |
| FY2019 | Dec 31, 2019 | -$16.65 | – |
| FY2018 | Dec 31, 2018 | -$21.00 | – |
| FY2017 | Dec 31, 2017 | -$14.10 | – |
| FY2016 | Dec 31, 2016 | -$40.13 | – |
| FY2015 | Dec 31, 2015 | -$81.00 | – |
| FY2014 | Dec 31, 2014 | -$42.75 | -507.1% |
| FY2013 | Dec 31, 2013 | $10.50 | – |
| FY2012 | Dec 31, 2012 | -$2.25 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $97.80 | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.20 | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.40 | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.55 | – |
| Q2 FY2022 | Jun 30, 2022 | -$8.10 | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.55 | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.45 | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.10 | – |
| Q4 FY2016 | Dec 31, 2016 | -$14.25 | – |
| Q3 FY2016 | Sep 30, 2016 | -$21.00 | – |
| Q2 FY2016 | Jun 30, 2016 | -$16.50 | – |
| Q1 FY2016 | Mar 31, 2016 | -$24.00 | – |
| Q4 FY2015 | Dec 31, 2015 | -$25.50 | – |
| Q3 FY2015 | Sep 30, 2015 | -$18.75 | – |
| Q2 FY2015 | Jun 30, 2015 | -$19.50 | – |
| Q1 FY2015 | Mar 31, 2015 | -$17.25 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?